A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer.

With the association of 5-fluorouracil (5-FU) and alpha-interferon (IFN), objective responses as high as 26 63% have been reported in untreated patients with advanced colorectal cancer. However, grade 3-4 toxicity has also been reported. We have conducted a prospective phase II randomised study comp...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Piga, A., Cascinu, S., Latini, L., Marcellini, M., Bavosi, M., Acito, L., Bascioni, R., Giustini, L., Francini, G., Pancotti, A., Rossi, G., Del Papa, M., Carle, F., Cellerino, R.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1996
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2074731/
https://ncbi.nlm.nih.gov/pubmed/8826868
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki